Clinical Trials Browser

Phase 1 × Thyrotropin Alfa × Head & Neck × Clear all

NCT02278198 2019-10-24

Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123

Phase 1 Completed

Thyroid Neoplasms